Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease.

Reactive oxygen species (ROS) are mediators of chronic tissue damage and fibrosis. Endogenous antioxidants may increase in response to oxidants and reduce tissue injury. We investigated the antioxidant response of the lungs to the chronic release of ROS, as occurs in the immune-specific granulomatous inflammation of chronic beryllium disease (CBD), and compared it with that in healthy controls and individuals exposed to cigarette smoke. The antioxidants superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), and glutathione (GSH) were quantitated in lung epithelial lining fluid (ELF) and serum from control subjects (n = 10), cigarette smokers (n = 8), and individuals with CBD (n = 9). GPx activity and extracellular GPx (eGPx) protein were increased in the ELF of subjects with CBD in comparison with that of control subjects and smokers (eGPx in ELF: controls, 1.3 +/- 0.2 microgram/ml, smokers, 1.9 +/- 0.3 microgram/ml, CBD, 3.8 +/- 0.8 microgram/ml; p = 0.002; GPx U/ml ELF, controls 1.4 +/- 0.3, smokers 1.8 +/- 0.4, CBD, 4.5 +/- 1, p = 0.02). Smokers' ELF had higher levels of GSH than that of controls, but CBD patients' ELF contained much more GSH than that of either controls or smokers (p < 0.001). Increases in GSH were correlated with eGPx, indicating similar inducing mechanisms for these antioxidants. Thus, coordinate augmentation of the glutathione antioxidant system occurs in granulomatous lung inflammation.

[1]  V. Kinnula,et al.  Manganese superoxide dismutase, but not CuZn superoxide dismutase, is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis. , 1998, American journal of respiratory and critical care medicine.

[2]  K. Vasquez,et al.  Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Kohno,et al.  Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. , 1997, American journal of respiratory and critical care medicine.

[4]  Xianglin Shi,et al.  The role of oxygen free radicals in occupational and environmental lung diseases. , 1997, Environmental health perspectives.

[5]  S. Erzurum,et al.  Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo. , 1997, The American journal of physiology.

[6]  L S Newman,et al.  Beryllium induces IL-2 and IFN-gamma in berylliosis. , 1997, Journal of immunology.

[7]  A. Cantin,et al.  Antioxidant activity in bronchoalveolar lavage fluid from patients with lung cancer. , 1996, American journal of respiratory and critical care medicine.

[8]  W. MacNee,et al.  Induction of γ‐glutamylcysteine synthetase by cigarette smoke is associated with AP‐1 in human alveolar epithelial cells , 1996 .

[9]  W. MacNee,et al.  Systemic oxidative stress in asthma, COPD, and smokers. , 1996, American journal of respiratory and critical care medicine.

[10]  V. Mohsenin,et al.  Adaptation of lung antioxidants to cigarette smoking in humans. , 1996, Chest.

[11]  T. Pietras,et al.  Increased content of hydrogen peroxide in the expired breath of cigarette smokers. , 1996, The European respiratory journal.

[12]  J. Willey,et al.  Extracellular glutathione peroxidase in human lung epithelial lining fluid and in lung cells. , 1996, The American journal of physiology.

[13]  W. MacNee,et al.  Induction of gamma-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. , 1996, FEBS letters.

[14]  K. Meyer.  Beryllium and lung disease. , 1994, Chest.

[15]  P. Carré,et al.  Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta. , 1994, American journal of respiratory cell and molecular biology.

[16]  K. Uchida,et al.  Identification of oxidized histidine generated at the active site of Cu,Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118. , 1994, The Journal of biological chemistry.

[17]  Y. Ishii,et al.  [Measurement of total glutathione concentration in bronchoalveolar lavage recovered from the patients with diffuse interstitial lung disease]. , 1994, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[18]  S. Tagami,et al.  Current smoking of elderly men reduces antioxidants in alveolar macrophages. , 1994, American journal of respiratory and critical care medicine.

[19]  L. S. Newman.  To Be2+ or not to Be2+: immunogenetics and occupational exposure. , 1993, Science.

[20]  R. Crystal,et al.  In vivo antioxidant gene expression in human airway epithelium of normal individuals exposed to 100% O2. , 1993, Journal of applied physiology.

[21]  A F Junod,et al.  Response of human endothelial cell antioxidant enzymes to hyperoxia. , 1992, American journal of respiratory cell and molecular biology.

[22]  N. Heintz,et al.  Differential regulation of antioxidant enzymes in response to oxidants. , 1991, The Journal of biological chemistry.

[23]  D. Lezotte,et al.  Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. , 1991, The Journal of allergy and clinical immunology.

[24]  T. Rushmore,et al.  The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. , 1991, The Journal of biological chemistry.

[25]  N. Milman,et al.  Comparison of alveolar macrophage and blood monocyte oxidative burst response in pulmonary sarcoidosis , 1990, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[26]  W. Calhoun,et al.  Heterogeneity in cell recovery and superoxide production in buoyant, density-defined subpopulations of human alveolar macrophages from healthy volunteers and sarcoidosis patients. , 1989, The Journal of laboratory and clinical medicine.

[27]  R. Crystal,et al.  Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. , 1989, The New England journal of medicine.

[28]  L. Frank,et al.  Rat lung Cu,Zn superoxide dismutase. Isolation and sequence of a full-length cDNA and studies of enzyme induction. , 1989, The Journal of clinical investigation.

[29]  M. Cullen,et al.  Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. , 1988, Annals of internal medicine.

[30]  D. Kriebel,et al.  The pulmonary toxicity of beryllium. , 1988, The American review of respiratory disease.

[31]  H. Witschi,et al.  Bronchoalveolar lavage in rats and mice following beryllium sulfate inhalation. , 1987, Toxicology and applied pharmacology.

[32]  C. Nathan,et al.  Hydrogen peroxide release by alveolar macrophages from sarcoid patients and by alveolar macrophages from normals after exposure to recombinant interferons alpha A, beta, and gamma and 1,25-dihydroxyvitamin D3. , 1987, The Journal of clinical investigation.

[33]  R. Crystal,et al.  Normal alveolar epithelial lining fluid contains high levels of glutathione. , 1987, Journal of applied physiology.

[34]  R. Crystal,et al.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. , 1986, Journal of applied physiology.

[35]  H. Aebi,et al.  Catalase in vitro. , 1984, Methods in enzymology.

[36]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.